Literature DB >> 3243734

In-vitro activity of seventeen antimicrobial compounds against seven species of mycobacteria.

C H Collins1, A H Uttley.   

Abstract

Within attainable serum concentrations, quinolones, especially ciprofloxacin, inhibited strains of Mycobacterium tuberculosis, M. xenopi, M. kansasii, M. fortuitum and M. marinum; vancomycin inhibited M. tuberculosis, the M. avium-intracellulare-scrofulaceum complex. M. kansasii, M. xenopi and M. chelonei; erythromycin was active against M. kansasii, M. xenopi and M. fortuitum, minocycline against M. kansasii and M. marinum and netilmicin and cefuroxime against M. xenopi. Aztreonam showed some activity against M. tuberculosis but little or no effect was shown by five cephalosporins or imipenem.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3243734     DOI: 10.1093/jac/22.6.857

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  5 in total

1.  Application of the Etest to the antimicrobial susceptibility testing of Mycobacterium marinum clinical isolates.

Authors:  C M Flynn; C M Kelley; M S Barrett; R N Jones
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

2.  Osteomyelitis and synovitis produced by Mycobacterium marinum in a fisherman.

Authors:  R B Clark; H Spector; D M Friedman; K J Oldrati; C L Young; S C Nelson
Journal:  J Clin Microbiol       Date:  1990-11       Impact factor: 5.948

3.  Ciprofloxacin once daily versus twice daily for the treatment of pulmonary tuberculosis.

Authors:  H Bergstermann; A Rüchardt
Journal:  Infection       Date:  1997 Jul-Aug       Impact factor: 3.553

4.  New anti-tuberculosis agents amongst known drugs.

Authors:  Kathryn E A Lougheed; Debra L Taylor; Simon A Osborne; Justin S Bryans; Roger S Buxton
Journal:  Tuberculosis (Edinb)       Date:  2009-08-20       Impact factor: 3.131

5.  Intracellular accumulation of norfloxacin in Mycobacterium smegmatis.

Authors:  S Corti; J Chevalier; A Cremieux
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.